Biocom California sees India on life sciences radar with its manufacturing prowess and scientific acumen
Joseph Panetta, president & CEO, Biocom California said, “It is India’s infrastructure for manufacture of biologics, biosimilars, qualified pool of scientific human resources and strong intellectual property rights’ (IPR) adherence that have been the three top attractive factors for us to be here and scout for potential opportunities in collaborations. Therefore, we are here to understand the industry, market prospects and engage in discussions with Indian biotech companies.
Avesthagen Limited enters into strategic alliance with Wipro; Launches breakthrough genetic testing portfolio for cancers, neurological and rare diseases
Avesthagen Limited, a biotechnology major that specializes in predictive, preventive and personalized healthcare through the convergence of food, pharma and population genetics, has entered into a four-year strategic alliance with Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO), a leading global information technology, consulting and business process services company, for making its genetic testing portfolio commercial. The portfolio includes genome panels offering highly specific, disease-centric analysis for conditions including cancers, neurodegenerative diseases, autoimmune disorders and rare disease conditions.
Biotech start-up Immuneel Therapeutics announces India’s first Phase II patient trials for CAR-T cancer therapies alongside a USD 15 million Series A financing
INDIA – Immuneel Therapeutics (‘Immuneel’), India’s leading biotech start-up focused on creating access to Chimeric Antigen Receptor T cell therapy (CAR-T) and other cellular immunotherapies for the management and treatment of cancers, has begun patient dosing in a CAR-T trial named “IMAGINE”. This phase II trial is the first industry sponsored CAR-T trial in India and is now actively enrolling patients at Narayana Hrudayalaya, Bengaluru.
Genomepatri Heritage, Mapmygenome’s DNA-based Ancestry Test Now Covers All of India
Genomepatri Heritage is Mapmygenome's DNA- based ancestry analysis, through which one can discover their ancestry roots. It is also one of our best-selling genomic tests. This heritage analysis now has comprehensive data on the ethnicity composition of every Indian state along with a global database.
Fighting Superbugs: How an Indian Avenger is building a life-saving weapon
Big pharma has little interest in antibiotics because there's not enough money in it, making Bugworks, with its R&D in India, among a handful of startups that is attempting the impossible